Introduction {#sec1-1}
============

Lichen planus (LP) is a chronic, commonplace immunological disease that affects the skin, mucous membranes, nails, and hair. Oral LP (OLP) is the oral manifestation of the same which protractedly and persistently involves the mucosa of the oral cavity. It commonly affects middle-aged females, and the frequency of malignant transformation ranges from 0% to 5.3%. The buccal mucosa followed by labial mucosa and sulci forms the most frequent intraoral sites of involvement.\[[@ref1]\]

The cause of the OLP is not well understood and is fraught with a multitude of hypothesis. Cell-mediated immunity is credited with a major aspect in the pathogenesis of OLP, and it may be initiated in individuals with a genetic predilection by various endogenous and exogenous factors. The various mechanisms hypothesized to be involved in the immune pathogenesis are antigen-specific, nonspecific mechanisms, autoimmune, and humoral immune responses. These mechanisms may combine to cause the accumulation of T-cells in superficial lamina propria, causing disruption of basement membrane, intraepithelial T-cell migration, and keratinocyte apoptosis in OLP.\[[@ref2]\]

Lipids are a group of fats and fat-like substances. They are essential biomolecules for maintenance of various biological functions, including stabilization of deoxyribonucleic acid helix, cell growth, and division in normal as well as in malignant tissues. The serum lipids are measured through their carrier lipoproteins, namely high-density lipoprotein (HDL), very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and triglyceride. The concentration of blood lipids depends on intake and excretion from the intestine and uptake and secretion from cells. The usefulness of variations in blood cholesterol levels in diagnosis and treatment of various diseases has been studied. An increase in the level of cholesterol is a major risk factor for coronary heart diseases; on the other hand, a decrease in the level of cholesterol has been associated with an increased risk of cancer.\[[@ref3][@ref4]\]

Absorbed fatty products in lieu of triglyceride enter the circulation as chylomicrons which are then broken down by lipoprotein lipase into HDL, LDL, and VLDL, respectively. The lipid--protein complex called lipoproteins enables the transport through bloodstream and is a reliable indicator for the respective lipids in the blood. Chronic inflammation induced in immune-mediated diseases instigates discrepancies in lipid metabolism as it endeavors to dilute the destruction and repair tissue by redistributing nutrients to cells involved in the host defense. The inflammatory cascade activation induces a decrease in HDL-cholesterol (HDL-C), with impairment in reverse cholesterol transport, and parallel changes in apolipoproteins, enzymes, antioxidant capacity, and ATP-binding cassette A1-dependent efflux. This decrease in HDL-C and phospholipids could stimulate compensatory changes such as synthesis and accumulation of phospholipid-rich VLDL, which binds bacterial products and other toxic substances, resulting in hypertriglyceridemia. The final consequence is an increased accumulation of cholesterol in the cells. Thus, the classical lipid changes associated with the metabolic syndrome (increased triglycerides and decreased HDL-C) may be envisioned as a highly conserved evolutionary response aimed at tissue repair, resulting in cardiovascular disease risk.\[[@ref5]\]

In this vein, the study was taken up to probe into the possible correlation between OLP and serum lipid-level derangements and to detect the difference in clinical characteristics of OLP in association with altered serum lipid profile patterns.

Subjects and Methods {#sec1-2}
====================

The study was carried out to determine the association of altered serum lipid profile patterns in OLP patients. Ethical clearance was obtained from the Institutional Ethical Committee before conducting the study.

The study group comprised 60 patients, irrespective of age, presenting to the institution as outpatients who were examined and selected by three investigators. Using purposive sampling method, the study was conducted from January 2016 to July 2017. Based on the prevalence of OLP (0.1%--2.2%), keeping confidence limit (Z) at 95% and allowable error (d) at 5%, the sample size for the study was fixed at 30 cases and 30 controls.

They were classified into two groups:

Cases - 30 individuals with clinically and histopathologically diagnosed OLPControls - 30 age- and sex-matched individuals with apparently healthy oral mucosa.

Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} were the clinical photographs of the cases selected. The selected participants were explained in detail about the procedures involved and written informed consent was obtained from them. A detailed history was recorded and a thorough general physical examination was performed wherein the relevant history (age, gender) and clinical and histopathological details were noted in an especially prepared pro forma. This was followed by a detailed examination of the OLP lesions. Clinically diagnosed OLP lesions were then subjected to histopathological evaluation for confirmation following which symptomatic cases were managed by conventional therapy. The criteria for the case and control group selection were as follows.

![Reticular type of oral lichen planus characterized by white lacy striae](CCD-9-112-g001){#F1}

![Atrophic type of oral lichen planus characterized by erythematous areas with radiating white striae along the margins](CCD-9-112-g002){#F2}

Inclusion criteria {#sec2-1}
------------------

Patients with clinically and histopathologically diagnosed OLP -- modified WHO criteria 2003 (cases)Patients with apparently healthy oral mucosa on complete oral examination (controls)Patients not known to be suffering from any other endocrine or metabolic disordersPatients not on any medications that are known to alter serum lipid levels in the body.

Exclusion criteria {#sec2-2}
------------------

Pregnant patientsPatients known to be suffering from any medical condition that precludes them from undergoing an oral biopsy procedurePatients on dyslipidemia therapy and on therapy for OLPPatients with any other coexisting oral lesions.

Venous blood samples were collected from the patients in the case and control group for the assessment of individual serum lipid levels. It was assessed using Chemistry Analyzer-Beckman Coulter AU480 (Beckman Coulter Diagnostics Model: February 2016). The values were subsequently recorded in the respective pro forma. The obtained data were compared to standard values to assess for alteration in serum lipid levels. The standard values to assess serum lipid levels (American Endocrine Society clinical practice guidelines, 2011) are as follows:\[[@ref6]\]

Triglyceride \<150 mg/dlLDL-cholesterol (LDL-C) \<100 mg/dlHDL-C 40--60 mg/dlVLDL-cholesterol 2--30 mg/dl.

The data were tabulated and subjected to statistical analysis. Descriptive statistical procedures such as means, standard deviations, medians, minimum, maximum, and percentages were used to summarize all variables. Cramer\'s V-test was procured to measure the association between two nominal variables. *P* ≤ 0.05 was considered statistically significant. Microsoft Excel was used for data registration, and IBM SPSS Statistics (version 20.0, SPSS Inc., IBM) was used for statistical analyses.

Results {#sec1-3}
=======

In the study group of 60 participants, the average individual serum lipid levels, HDL, and triglyceride were confined to normal limits. However, LDL was of a normal average among cases and elevated in average among controls. Of interest was the elevated average VLDL among cases and the normal average in controls \[[Table 1](#T1){ref-type="table"}\].

###### 

Distribution of average individual serum lipid levels among cases and controls

![](CCD-9-112-g003)

Of the 30 cases, 46.67% of patients had dyslipidemia, and among the 30 controls, 23.33% of patients had dyslipidemia. A significant number of cases were found to have associated serum dyslipidemia in comparison to the controls. However, pertaining to individual serum lipid levels in cases and controls, the association was found to be statistically insignificant \[[Table 2](#T2){ref-type="table"}\].

###### 

Distribution of individual deranged serum lipid levels (dyslipidemia) among cases and controls

![](CCD-9-112-g004)

In the age range of 18--30 years among cases, dyslipidemia was noted only in HDL levels where 33.3% had decreased HDL levels and 33.33% had elevated HDL levels. In the age range of 31--45 years among cases, 18.33% had elevated LDL levels, 8.33% had elevated VLDL levels, and 16.6% had elevated triglyceride levels. In the age range of 46--60 years among cases, 7.69% demonstrated elevated HDL levels, 15.38% had elevated LDL levels, 30.76% had elevated VLDL levels, and 23.07% had elevated triglyceride levels. In the age range of \>60 years among cases, 50.0% had elevated VLDL levels and 50.0% patients had elevated triglyceride levels. However, the age-wise distribution pertaining to dyslipidemia was statistically insignificant \[[Table 3](#T3){ref-type="table"}\].

###### 

Age wise distribution of cases based on serum lipid levels

![](CCD-9-112-g005)

Among the 30 cases, 43.33% of patients demonstrated dyslipidemia, of which 23.33% of patients were female and 20% of patients were male. It was determined that association between serum lipid levels and gender-wise distribution was insignificant \[[Table 4](#T4){ref-type="table"}\].

###### 

Gender-wise distribution of serum lipid profile in cases

![](CCD-9-112-g006)

In the case group of 30 patients, 36.67% of patients were asymptomatic and 63.33% of patients were symptomatic. However, the association between dyslipidemia and symptoms in OLP was found to be statistically insignificant \[[Table 5](#T5){ref-type="table"}\].

###### 

Symptom-wise and serum lipid profile distribution of cases

![](CCD-9-112-g007)

Pertaining to OLP, dyslipidemia, and its association to the site of presentation, 17 patients had presentation on bilateral buccal mucosa, seven patients on bilateral buccal mucosa and gingiva, and six patients on the bilateral buccal mucosa and tongue. However, the association of OLP patients with dyslipidemia according to the site of presentation was deemed statistically insignificant \[[Table 6](#T6){ref-type="table"}\].

###### 

Distribution of cases pertaining to site and serum lipid levels

![](CCD-9-112-g008)

On consideration OLP subtypes and dyslipidemia association, it was noted that 22 cases had reticular-type OLP, eight cases had atrophic-type OLP, and 14 patients demonstrated dyslipidemia. Inasmuch, the association was statistically insignificant \[[Table 7](#T7){ref-type="table"}\].

###### 

Oral lichen planus subtypes distribution in dyslipidemia

![](CCD-9-112-g009)

Discussion {#sec1-4}
==========

OLP is a T-cell-mediated, chronic inflammatory oral mucosal disease of unknown etiology. Several factors have been proposed contributing to etiology including genetic background, dental materials, drugs, infectious agents, autoimmunity, immunodeficiency, food allergies, stress, habits, trauma, diabetes, hypertension, malignant neoplasm, and bowel disease.\[[@ref7]\] It is interesting to note that quite a few skin diseases such as androgenic alopecia and psoriasis have been inseverably linked to cardiovascular risk factors.\[[@ref5]\] The current interest is the associated serum lipid derangement of note in OLP patients, which in turn has been linked to increased cardiovascular risk.

Furthermore, among other studies, the term "dyslipidemia" when scrutinized was categorized as a broader terminology, i.e., elevation in total cholesterol and triglyceride. The terminology in actuality encompasses all the lipid levels, i.e. HDL, LDL, VLDL, and triglycerides. Thus, ideally, any elevation or depression of the aforementioned levels would umbrella under the terminology "dyslipidemia." To be explicit and eradicate the probable disadvantage imposed by these factors, individual serum lipid levels were recorded and compared among the two groups in our study.

A case--control study by Dreiher *et al*. discovered that LP was irrefutably associated with dyslipidemia in the patient series. The authors implied that LP was previously reported to be associated with abnormal carbohydrate metabolism in epidermal cells and that the chronic inflammation associated with the condition conducive to dyslipidemia.\[[@ref8]\]

Thereafter, in another study by Arias-Santiago *et al*., comprising 200 patients, a higher significant prevalence of dyslipidemia was revealed in patients with LP (cutaneous and oral). Authors suggested the possible association of dyslipidemia with the pathogenesis of OLP, concluding that the chronic inflammation induced as the reason, thus increasing the cardiovascular risk in such subjects.\[[@ref9]\]

None of the studies elucidated the association of individual serum lipid level alteration with OLP lesions in a specific age and gender, its type, site, and associated symptoms. We hypothesized that all these could be a variable in association of serum lipid level alteration in OLP. In our study, of the 30 cases, 13 (46.67%) patients had deranged serum lipid levels, of which two subjects had depressed HDL, two subjects had elevated LDL level, eight subjects had elevated VLDL level, and seven subjects had elevated triglyceride levels. The results of the present study are consistent with those of a study by Dreiher *et al*.\[[@ref8]\] and Arias *et al*.\[[@ref9]\] It was to be emphasized that the derangement was not confined to total cholesterol and triglyceride alone but included HDL, LDL, and VLDL as well. The gravity of this finding can be substantiated by the findings of Krishnamoorthy *et al*., wherein it is elaborated that chronic inflammation induced in immune-mediated diseases instigates disturbances in lipid metabolism as it aims at decreasing the toxicity of the harmful agents and tissue repair by redistributing nutrients to cells involved in the host defense. The activation of the inflammatory cascade will induce a decrease in HDL-C that could stimulate compensatory changes such as synthesis and accumulation of phospholipid-rich VLDL, which binds bacterial products and other toxic substances, resulting in hypertriglyceridemia. The final consequence is an increased accumulation of cholesterol in cells.\[[@ref10]\] When the compensatory response (inflammation) is not able to repair injury, it turns into a harmful reaction, and the lipid changes will become chronic, either by repeated or overwhelming stimulus, enhancing the formation of atherosclerotic lesions. Thus, the classical lipid changes associated may be envisioned as a highly conserved evolutionary response aimed at tissue repair.\[[@ref5]\]

The subjects were grouped into six categories based on the age ranges, viz., 18--30 years, 31--40 years, 41--50 years, 51--60 years, and \>60 years. Although it is an established fact that dyslipidemia has an inclination toward the aging population, in the present study, it was centered on the diseased patients. Among the cases that demonstrated dyslipidemia, 37% of patients were in the middle age, i.e. 31--40 years and 41--50 years of age group. This was in standing with the fact that OLP is a disease of middle age. The association of dyslipidemia and age-wise distribution of patients with OLP, however, was found to be statistically insignificant.

In addition, the association between dyslipidemia and different site involvements in patients with OLP was assessed. Of the 17 patients among case group demonstrating dyslipidemia, 12 patients had only on bilateral buccal mucosa, five patients had on bilateral buccal mucosa and gingival, whereas three patients had on bilateral buccal mucosa and tongue. A significant preponderance to a site in association with dyslipidemia could neither be drawn out nor could an affiliation be drawn between the severity of OLP and the sites of appearance. The results of the present study demonstrated that patients with OLP unequivocally had a significant lipid alteration. The lipid profile, including HDL, VLDL, LDL, and triglyceride levels, was deranged with no significant differences between the various subtypes of OLP. The subtypes or the severity of OLP was not a confounding factor as clarified subsequently and found to be statistically insignificant.

In an interesting study by Shaynam *et al*., high-stress levels in individuals correlated with high TC, high LDL-C, and low HDL-C compared to individuals with normal lipid profile. It was postulated that stress increased blood lipids through increasing hepatic lipoprotein lipase activity caused by a heightened sympathetic neuronal response. The association of dyslipidemia and stress level of the patient could positively correlate with the occurrence of OLP. However, this aspect was above and beyond the scope of this study and perhaps a limitation as well. Further, during the course of our study, it was of notice that social standing and lifestyle would factor in the disease process. Of consideration was that a majority of diseased patients were in low or lower middle economic classification. This in turn affects the stress levels pertaining to finance and even more importantly determines the nutrition status by cause and effect. We recommend further studies with larger samples to probe this possible association.

Conclusions {#sec1-5}
===========

The denouement was that an association between OLP and dyslipidemia is not one that has been thoroughly explored, and considering the results of the current study, we attain a conclusion that a link is certain. Hence, prowling dyslipidemia must be investigated for, when evaluating a patient with OLP for it signals a much dangerous cardiovascular disease. Conversely, a medical professional evaluating dyslipidemia must be vigilant of an enshrouded OLP or perhaps even susceptibility to developing it. Although, in association with OLP, the serum lipids are likely to be elevated, depression of serum lipid levels could be an ill-omened directive of malignant change that needs to be explored further. Further, the lesions of OLP in dyslipidemia subjects were surveyed, and we explicated no typical characteristics of OLP in dyslipidemia.
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